#miv cel stiff person syndrome

CAR-T Therapy Cures Stiff Person Syndrome: A Medical Breakthrough in 2026

Kyverna Therapeutics' miv-cel CAR-T therapy successfully treated Stiff Person Syndrome in a Phase 2 trial: 81% of patients improved mobility and 67% abandoned wheelchairs in 16 weeks.